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Commentary 
Molecular Genetics in Breast Cancer: Signaling Pathways and 
Tumor Biology 
Breast cancer is one of the common cancers among the women in which 
many factors are involved including oncogenes, tumor suppressor genes, 
different signaling pathways, epigenetic and environmental factors such as 
inflammation, immune system deficiency, genomic instability as well as 
Warburg effect that play an important role in the development and spread of 
cancer as well as cellular metabolism that intensifies the process. There are 
some evidence that cancer stem cells (CSCs) are responsible for tumor 
initiation, invasion, maintenance, heterogeneity, metastasis, and resistance to 
treatment. CSCs may be an important target for an effective treatment due to 
the fact that these cells are responsible for metastasis and resistance to 
treatment. Learning these various factors, we can take a great step towards 
better understanding of this type of cancer and help further to treatment of 
the disease so that, cancer cells become not resistant to chemotherapy and 
we can take the best possible outcome of our treatment, although breast 
cancer is very heterogeneous and is associated with many cases such as cell 
morphology, cell physiology, cell gene expression, metabolism, etc. 
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Certainly, many genetic factors are involved in 
observing breast cancer in a woman such as Proto-
oncogenes (RAS and NYC) and signaling pathways 
PI3K-AT-mTOR and tumor suppressors (BRCA1 
and BRCA2), although each factor doesn’t have an 
effective role, alone (1). Also, issues such as 
inflammation, immune system defects, genomic 
instability (2) as well as Warburg effect are involved 
in the development and spread of cancer (3). On the 
other hand, cellular metabolism intensifies this 
process by producing bio-molecules such as 
pyruvate, lactate and ketone bodies (4). Proficiency 
in each of these sectors can be used in personalized 
treatment (5). 
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as Reactive oxygen species caused by Nuclear factor 
and NFE2L2 can be restored (6,7). 
Carcinogenesis process becomes lower when the 
cell is subjected to poverty and energy crisis (8). 
Environmental factors include cigarette smoke (9) 
and prolonged exposure to ethanol. Also, viral 
infections, obesity, allergens, radiation, toxic 
chemicals and other environmental factors are 
sometimes the microbial factors other than 
environmental factors (10). Most of the above cases 
are considered as the epigenetic changes (11). 
Although, breast cancer is very heterogeneous and is 
associated with many cellular cases such as 
morphology, cell physiology, cell origin, surface 
markers, the level of gene expression in cells, 
metabolism and metastasis potential (12). 
According to their versatility with their environment, 
breast cancer cells acquire drug resistance 
properties, too (13,14) and that makes them resistant 
to chemotherapy (15,16). Although, chemotherapy 
and radiotherapy have been occasionally seen to 
cause increased ROS levels in cells (17-19) . 
Mitochondrial accumulation causes up-regulated 
Wnt/β-catenin (20). that the production of 
mitochondria is associated with ERRα-PGC1 
signaling pathway and stopping the molecular 
pathways is associated with sonic hedgehog TGF β –
SMAD, STAT3 which are the major pathways in the  
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carcinogenic process (21). Overcoming the 
resistance to chemotherapy and radiotherapy in solid 
tumors is one of the fundamental problems in the 
clinical oncology. A significant percentage of 
resistance to the treatment as well as metastasis and 
recurrence processes can be attributed to cancer stem 
cells (CSCs) (22,23). Breast cancer stem cells 
(BCSCs) showed a high level of activity of Wnt, 
Notch, Hedgehog, JAK/STAT and Nuclear factor-
kappa B (NF-κB) and these pathways set the process 
of differentiation and self-renewal(24). CSCs may 
be an important target for an effective treatment due 
to the fact that these cells are responsible for 
metastasis and resistance to treatment(25). 
Figure1:This model shown to us metabolic coupling in tumor metabolism, such as: Warburg effect, ROS-mediated pseudo hypoxia/ 
survival mechanism, Lactate efflux/uptake, Anabolism/Catabolism, Autophagy, high mitochondrial mass. 
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Conclusion 
In this study, we explain the various factors involved in breast cancer; although, breast cancer is a 
heterogeneous disease in which many factors are involved but certainly, being mastered in any above-
mentioned factors can help us in the future individual treatment . 
